BioXcel Therapeutics Inc (NAS:BTAI)
$ 1.325 (0%) Market Cap: 40.91 Mil Enterprise Value: 124.02 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 14/100

BioXcel Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 12, 2025 / 02:00PM GMT
Release Date Price: $2.01 (-2.90%)
Operator

Good morning, ladies and gentlemen, and welcome to the BioXcel Therapeutics annual meeting of stockholders. I will now turn the meeting over to Dr. Peter Mueller. Please go ahead.

Peter Mueller
BioXcel Therapeutics Inc - Chairman of the Board at BioXcel Therapeutics Inc

Good morning, everybody. I'm Dr. Peter Mueller, the Chairman of the Board of Directors of BioXcel Therapeutics and the Chairperson of today's meeting. I'm very happy to welcome you to our annual meeting of stockholders.

Before I call the meeting to order, I'd like to introduce you also to Vimal Mehta, our Chief Executive Officer and Founderp and Richard Steinhart, our Chief Financial Officer and Javier Rodriguez, our Chief Legal Officer.

The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in the notice of annual meeting and proxy statement. The time is now exactly 9:00 AM Eastern Time and the polls are now open for voting on all matters before the meeting.

If you have not already voted and wish to vote,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot